Literature DB >> 12969123

Renal expression of angiotensin type 2 (AT2) receptors during kidney damage.

Marta Ruiz-Ortega1, Vanesa Esteban, Yusuke Suzuki, Mónica Ruperez, Sergio Mezzano, Leopoldo Ardiles, Pilar Justo, Alberto Ortiz, Jesús Egido.   

Abstract

BACKGROUND: Activation of the renin angiotensin system has been described in pathologic conditions, including kidney damage. Angiotensin II (Ang II) acts through two receptors, AT1 and AT2. Most of the known actions of Ang II, including vasoconstriction and fibrosis, are due to AT1 activation. Recent data suggest that AT2 participates in the regulation of cell growth and renal inflammatory infiltration. Therefore, we investigated the renal expression of AT2 receptors in several models of renal injury.
METHODS: Investigations were done in the following experimental models of kidney damage: systemic infusion of Ang II (inflammation), folic acid nephropathy (tubular cell death), and protein overload proteinuria. AT2 expression was determined by immunohistochemistry (protein) and reverse transcription-polymerase chain reaction (RT-PCR) (gene).
RESULTS: In control animals, low levels of renal expression of AT2 were found. Ang II infusion resulted in an up-regulation of AT2 in tubular cells and de novo AT2 expression in glomeruli and vessels, associated with the presence of inflammatory cells. Acute tubular injury induced by folic acid was characterized by AT2 overexpression and apoptosis in tubular cells. Protein overload caused heavy proteinuria and tubular AT2 up-regulation.
CONCLUSION: AT2 is re-expressed in pathologic conditions of kidney damage, such as inflammation, apoptosis, and proteinuria, suggesting a potential role of this receptor during renal injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969123     DOI: 10.1046/j.1523-1755.64.s86.5.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  21 in total

1.  Angiotensin AT₂ receptor stimulation inhibits early renal inflammation in renovascular hypertension.

Authors:  Luis C Matavelli; Jiqian Huang; Helmy M Siragy
Journal:  Hypertension       Date:  2010-12-28       Impact factor: 10.190

Review 2.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

3.  Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN.

Authors:  Partab Rai; Rivka Lederman; Shabirul Haque; Shabina Rehman; Viki Kumar; Kavithalakshmi Sataranatrajan; Ashwani Malhotra; Balakuntalam S Kasinath; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2014-04-21       Impact factor: 3.362

Review 4.  AT2 receptor activities and pathophysiological implications.

Authors:  Luis C Matavelli; Helmy M Siragy
Journal:  J Cardiovasc Pharmacol       Date:  2015-03       Impact factor: 3.105

5.  Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age.

Authors:  Jeffrey S Gilbert; Alvin L Lang; Angela R Grant; Mark J Nijland
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

6.  HIV-associated nephropathy: role of AT2R.

Authors:  Divya Salhan; Ankita Sagar; Dileep Kumar; Rungwasee Rattanavich; Partab Rai; Subani Maheshwari; Madhuri Adabala; Mohammad Husain; Guohua Ding; Ashwani Malhotra; Praveen N Chander; Pravin C Singhal
Journal:  Cell Signal       Date:  2011-11-13       Impact factor: 4.315

Review 7.  Key developments in renin-angiotensin-aldosterone system inhibition.

Authors:  Bruno Sevá Pessôa; Nils van der Lubbe; Koen Verdonk; Anton J M Roks; Ewout J Hoorn; A H Jan Danser
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

8.  Regulation of T-cell function by endogenously produced angiotensin II.

Authors:  Nyssa E Hoch; Tomasz J Guzik; Wei Chen; Tenecia Deans; Samer A Maalouf; Petra Gratze; Cornelia Weyand; David G Harrison
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-10       Impact factor: 3.619

9.  A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade.

Authors:  Hirokazu Okada; Tsutomu Inoue; Tomohiro Kikuta; Yusuke Watanabe; Yoshihiko Kanno; Shinichi Ban; Takeshi Sugaya; Masatsugu Horiuchi; Hiromichi Suzuki
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

10.  Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes.

Authors:  A Koïtka; Z Cao; P Koh; A M D Watson; K C Sourris; L Loufrani; A Soro-Paavonen; T Walther; K J Woollard; K A M Jandeleit-Dahm; M E Cooper; T J Allen
Journal:  Diabetologia       Date:  2009-12-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.